Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 2562 | 425 | 0.3053 | 0.3034 | 0.1659 | 0.1673 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2637 | 462 | 0.3107 | 0.3034 | 0.1752 | 0.1673 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1252 | 898 | 0.0506 | 0.0508 | 0.7173 | 0.7144 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1208 | 870 | 0.0483 | 0.0508 | 0.7202 | 0.7144 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1275 | 900 | 0.0536 | 0.0508 | 0.7059 | 0.7144 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1374 | 845 | 0.0756 | 0.0722 | 0.6150 | 0.5817 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1227 | 686 | 0.0773 | 0.0722 | 0.5591 | 0.5817 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1042 | 595 | 0.0639 | 0.0722 | 0.5710 | 0.5817 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1347 | 812 | 0.0764 | 0.0748 | 0.6028 | 0.5989 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1274 | 753 | 0.0744 | 0.0748 | 0.5911 | 0.5989 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1297 | 782 | 0.0736 | 0.0748 | 0.6029 | 0.5989 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1706 | 704 | 0.1431 | 0.1375 | 0.4127 | 0.4603 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1621 | 824 | 0.1139 | 0.1375 | 0.5083 | 0.4603 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2014 | 926 | 0.1554 | 0.1375 | 0.4598 | 0.4603 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 840 | 724 | 0.0166 | 0.0153 | 0.8619 | 0.8976 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 1187 | 1073 | 0.0163 | 0.0153 | 0.9040 | 0.8976 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 1258 | 1166 | 0.0131 | 0.0153 | 0.9269 | 0.8976 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1426 | 1207 | 0.0313 | 0.0266 | 0.8464 | 0.8544 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1286 | 1097 | 0.0270 | 0.0266 | 0.8530 | 0.8544 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 1108 | 957 | 0.0216 | 0.0266 | 0.8637 | 0.8544 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1198 | 988 | 0.0300 | 0.0300 | 0.8247 | 0.8251 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1120 | 918 | 0.0289 | 0.0300 | 0.8196 | 0.8251 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 1290 | 1072 | 0.0311 | 0.0300 | 0.8310 | 0.8251 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1509 | 1201 | 0.0440 | 0.0314 | 0.7959 | 0.8595 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1560 | 1386 | 0.0249 | 0.0314 | 0.8885 | 0.8595 |